Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2022年9月1日
	新闻
	Amgen's Lumakras threatens Mirati with lung cancer trial win - Fierce Pharma Fierce Pharma ... off tumor progression or death in previously treated patients with KRAS G12C-mutated non-small cell lung cancer, the company said Tuesday. 标记为不相关
	MA Researchers Create AI Algorithm to Enhance Lung Cancer Radiation Therapy HealthITAnalytics Research from Brigham and Women's Hospital shows that providers can save time and bandwidth on lung cancer radiation therapy with the help of a ... 标记为不相关
	Amgen says KRAS drug beat chemo in lung cancer study | BioPharma Dive BioPharma Dive Lumakras is the first drug approved to treat cancers caused by mutations in a gene called KRAS. Frequently mutated in lung, colon and pancreatic ... 标记为不相关
	Novel Drug Will Be Evaluated for EGFR-TKI—Mutant Lung Cancer - Cure Today Cure Today The first patient has been treated with H002, a novel drug being investigated for non-small cell lung cancer that is resistant to a prior EGFR TKI ... 标记为不相关
	Drug combo therapy in mice blocks drug resistance, halts tumor growth - ScienceDaily ScienceDaily An experimental combination of two drugs halts the progression of small cell lung cancer, the deadliest form of lung cancer, according to a study ... 标记为不相关
	Sotorasib extends PFS in lung cancer subset - Healio Healio Sotorasib prolonged PFS compared with standard chemotherapy for certain patients with non-small cell lung cancer, according to topline data ... 标记为不相关
	With Phase III Win in Lung Cancer, Amgen's Lumakras Puts Pressure on Mirati | BioSpace BioSpace Since then, the pharma giant has also initiated a Phase III study of the drug in colorectal cancer, while continuing several studies in lung cancer. 标记为不相关
	Lung-MAP Trial of Pembrolizumab/Ramucirumab Improves Overall Survival in NSCLC Targeted Oncology ... discusses the key findings of the phase 2 Lung-MAP substudy S1800A for patients with stage IV, previously-treated non–small cell lung cancer. 标记为不相关
	Former smoker's lung cancer fears despite not having touched a cigarette in 40 years Lancs Live A Rossendale man is urging Lancashire residents to take part in a free 'health MOT' in a bid to help diagnose more people with lung cancer earlier ... 标记为不相关
	Oncocyte Nets $3M VA Contract for DetermaRx Lung Cancer Prognostic Test Precision Oncology News The test will be covered by the VA for five years to determine the risk of recurrence in early-stage lung cancer patients after surgery. 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈